← Back to headlines
Wolfe Research Maintains Outperform Rating on AnaptysBio
Analysts at Wolfe Research reaffirmed their Outperform stock rating for biotechnology firm AnaptysBio, citing positive fundamentals and pipeline prospects.
31 Aug, 10:24 — 31 Aug, 10:24
Sources
Showing 1 of 1 sources
